Rubicon Research Private Limited has recalled 3,984 bottles of Acetazolamide (125 mg) tablets because of reports of tablet discoloration. This prescription medication is distributed by Advagen Pharma Limited in 100-count bottles. Consumers using this medication should speak with their doctor or pharmacist regarding their treatment and how to handle the affected product.
The recall was initiated because the tablets may show discoloration, which is a defect in the product's appearance and quality. While this is a low-risk recall, using discolored medication may lead to patient concern or potential changes in the drug's effectiveness.
You have 2 options:
Distributed by Advagen Pharma Limited, Plainsboro, NJ. Manufactured by Rubicon Research Private Limited, Thane, India.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.